In April 2015, USAID and Janssen Therapeutics officially launched the bedaquiline donation initiative, under which Janssen committed to providing free bedaquiline to 30,000 patients with multidrug-resistant tuberculosis (MDR-TB) over a four-year period. Bedaquiline is the first anti-TB medicine to be approved by the U.S. Food and Drug Administration in more than 40 years, and is … Read more
This brief demonstrates how more than USD 102 million has been saved or mobilized as a result of SIAPS/USAID assistance in supporting the implementation of the National Pharmaceutical System in the Dominican Republic.
By Emily Delmotte, SIAPS Technical Advisor This has been cross-posted with the permission of Science Speaks. The text has been changed slightly for clarity. Eight years ago Busisiwe Beko was undergoing treatment for multidrug-resistant tuberculosis (MDR-TB) when, after months of waiting to see a pediatric specialist, her daughter was diagnosed with the same illness. The … Read more
On March 26, Dr. Maheen Malik, Senior Technical Advisor for the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program and Management Sciences for Health (MSH), briefed the Congressional Women’s Caucus on strengthening the health workforce in fragile countries. This blog is re-posted from the MSH website. It … Read more